ISOVUE 200 is a Intravascular Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Bipso Gmbh. The primary component is Iopamidol.
Product ID | 76381-314_5c4ac062-d59d-f667-f218-1572e3d8cde8 |
NDC | 76381-314 |
Product Type | Human Prescription Drug |
Proprietary Name | ISOVUE 200 |
Generic Name | Iopamidol |
Dosage Form | Injection, Solution |
Route of Administration | INTRAVASCULAR |
Marketing Start Date | 1985-12-31 |
Marketing Category | NDA / NDA |
Application Number | NDA018735 |
Labeler Name | BIPSO GmbH |
Substance Name | IOPAMIDOL |
Active Ingredient Strength | 408 mg/mL |
Pharm Classes | Radiographic Contrast Agent [EPC],X-Ray Contrast Activity [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |
Marketing Start Date | 1985-12-31 |
NDC Exclude Flag | N |
Sample Package? | N |
Ingredient | Strength |
---|---|
IOPAMIDOL | 408 mg/mL |
SPL SET ID: | 764f5085-7ee8-fdba-2c5b-ae6721014a94 |
Manufacturer | |
UNII |
NDC | Brand Name | Generic Name |
---|---|---|
76381-314 | ISOVUE 200 | ISOVUE 200 |
0270-1314 | ISOVUE | IOPAMIDOL |
0270-1315 | ISOVUE | IOPAMIDOL |
0270-1316 | ISOVUE | IOPAMIDOL |
0270-1317 | ISOVUE | IOPAMIDOL |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
ISOVUE 85423219 4243227 Dead/Cancelled |
Centrix, Inc. 2011-09-15 |
ISOVUE 75239760 2132582 Dead/Cancelled |
BRACCO DIAGNOSTICS, INC. 1997-02-07 |
ISOVUE 73299442 1237972 Live/Registered |
E. R. Squibb & Sons, Inc. 1981-02-25 |